GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93019C00003EMINENT SERVICES CORP

Overview

Award facts

Net obligations
$19.80M
$19,798,741of $19.80M potential value
Outlays (paid to date)
$14.93M
$14.93M paid of $19.80M obligated$14,927,805
Period of performance
Apr 1, 2019 to Mar 31, 2026
Ended
Modifications
27
Latest action Jan 29, 2026
Contract type
Definitive contract
PIID 75N93019C00003

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF NIAID DIVISION OF ALLERGY, IMMUNOLOGY&TRANSPLANTATION: IMMUNE MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC)

Dates and value

Award date
Signed on Mar 28, 2019
Potential end of performance
Mar 30, 2026
Current value
$19,798,741Base and exercised options
Potential value (if all options are exercised)
$19,798,741

Obligations by fiscal year of action

  • FY2026: $980,085
  • FY2025: $2,310,128
  • FY2024: $3,717,241
  • FY2023: $5,201,652
  • FY2022: $2,876,783
  • FY2021: $1,618,899
  • FY2020: $1,814,722
  • FY2019: $1,279,231

Total across 8 fiscal years: $19,798,741

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 29, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEIC4PUY1BKHP59
CAGE code313T8
Business sizeSmall businessSize at award, per the contracting officer
Parent companyEMINENT SERVICES CORP

Business types and certifications

Minority-ownedFor-profit organizationManufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21703-9401
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
2

Solicitation and notices

Solicitation ID
NIAIDDAITNIHAI2017096(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Mar 28, 2019Base obligation at award: $1,279,231
Latest action
Jan 29, 2026 — Change orderModification P00027; obligation change +$980,085
Latest substantive action
Jan 29, 2026 — Change orderModification P00027; obligation change +$980,085
Latest funding action
Feb 27, 2025 — Funding onlyModification P00024; obligation change +$226,289; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised13
  • Funding only11
  • Supplemental agreement (within scope)1
  • Change order1
  • Other administrative action1
28 actions recorded, Mar 28, 2019 to Jan 29, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$980,085
Latest action: change in base and all options
$980,085

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
28

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2019/2019-0885-000
  • 075-2020/2020-0885-000
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
Show all 9 accounts
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
  • 075-2026/2026-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$999,165
COVID-19 supplemental outlays
$999,165